References
- Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176(6):532–555. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17507545.
- Sethi S, Evans N, Grant BJB, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002; 347(7):465–471. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12181400.
- Larsen M V, Janner JH, Nielsen SD, Friis-Møller A, Ringbaek T, Lange P. Bacteriology in acute exacerbation of chronic obstructive pulmonary disease in patients admitted to hospital. Scand J Infect Dis 2009; 41(1):26–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18855228.
- Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106(2):196–204. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3492164.
- Van der Valk P, Monninkhof E, van der Palen J, Zielhuis G, van Herwaarden C, Hendrix R. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease. Clin Infect Dis 2004; 39(7):980–986. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15472849.
- Braude AC, Cohen RD, Penner JL, Preston MA, Rebuck AS. Pulmonary disposition of moxalactam. Chest 1984; 86(6):881–883. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6499551.
- Maesen FP, Davies BI, Baur C. Amoxycillin/clavulanate in acute purulent exacerbations of chronic bronchitis. J Antimicrob Chemother 1987; 19(3):373–383. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3494724
- Brusse-Keizer M, ten Bokum L, Movig K, van der Valk P, Kerstjens H, van der Palen J, et al. Relation between amoxicillin concentration in sputum of COPD patients and length of hospitalization. COPD 2011; 8(2):66–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21495834.
- Brusse-Keizer M, VanderValk P, van der Zanden R, Nijdam L, van der Palen J, Hendrix R, et al. Amoxicillin concentrations in relation to beta-lactamase activity in sputum during exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2015; 10:455–461.
- Stockley RA, Hill SL, Burnett D. Nebulized amoxicillin in chronic purulent bronchiectasis. Clin Ther 1985; 7(5):593–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4053147.
- Hill SL, Morrison HM, Burnett D, Stockley RA. Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation. Thorax 1986; 41(7):559–65. Available from: http://www.pubmedcentral.nih.govarticle render.fcgi?artid = 460390&tool = pmcentrez&rendertype = abstract.
- Le J, Ashley ED, Neuhauser MM, Brown J, Gentry C, Klepser ME, et al. Consensus summary of aerosolized antimicrobial agents: application of guideline criteria. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 2010; 30(6):562–584. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20500046.
- J. Denyer et al. Does inhalation duty cycle in vitro predict inhaled dose during domiciliary nebulizer use? The aerosol society, Drug delivery to the lungs VIII. 1998; doi:10.1089/jam.1998.11.177.
- Ho SL, Kwong WT, O’Drowsky L, Coates AL. Evaluation of four breath-enhanced nebulizers for home use. J Aerosol Med 2001; 14(4):467–475. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11791687.
- Le Brun PP, de Boer AH, Gjaltema D, Hagedoorn P, Heijerman HG, Frijlink HW. Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer. Int J Pharm 1999; 189(2):205–214. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10536249.
- Westerman EM, Le Brun PPH, Touw DJ, Frijlink HW, Heijerman HGM. Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: A pilot study. J Cyst Fibros 2004; 3(1):23–28.
- European Committee on Microbial Susceptibility Testing (Eucast). Available from: http://www.eucast.org/clinical_breakpoints/ (accessed 12 November 2013).
- Gould IM, Harvey G, Golder D, Reid TM, Watt SJ, Friend JA, et al. Penetration of amoxycillin/clavulanic acid into bronchial mucosa with different dosing regimens. Thorax 1994; 49(10):999–1001. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7974318.